Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

NCT01254279 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
984
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi